Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
- A. Schrock, S. Li, +19 authors J. Liu
- Medicine
- Journal of thoracic oncology : official…
- 1 June 2017
Introduction: Pulmonary sarcomatoid carcinoma (PSC) is a high‐grade NSCLC characterized by poor prognosis and resistance to chemotherapy. Development of targeted therapeutic strategies for PSC has… Expand
Preoperative evaluation of hepatic lesions for the staging of hepatocellular and metastatic liver carcinoma using endoscopic ultrasonography.
- S. Awad, Shawn P. Fagan, Suhaib Abudayyeh, N. Karim, D. Berger, K. Ayub
- Medicine
- American journal of surgery
- 1 December 2002
BACKGROUND
Noninvasive imaging techniques, such as dynamic computed tomography (CT), magnetic resonance imaging and transabdominal ultrasonography are limited in their ability to detect hepatic… Expand
Nutritional Status among Chinese Preschoolers in Subang Jaya, Selangor.
A nutritional status study was carried out among Chinese preschoolers (4- 6 years old) residing in Subang Jaya, Selangor. 91 preschoolers (48 boys and 43 girls) of Chinese descent participated in the… Expand
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
- T. Wise-Draper, G. Moorthy, +12 authors J. Morris
- Medicine
- Targeted Oncology
- 29 March 2017
BackgroundThe combination of everolimus and the imidazoquinoline derivative, BEZ235 (dactolisib), a dual PI3K/mTOR inhibitor, demonstrated synergy in a preclinical model.ObjectiveTo establish… Expand
Influenza Vaccination in Cancer Patients Undergoing Systemic Therapy
- M. Shehata, N. Karim
- Medicine
- Clinical Medicine Insights. Oncology
- 1 January 2014
Background Cancer patients often experience preventable infections, including influenza A and B. These infections can be a cause of significant morbidity and mortality. The increased risk of… Expand
A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC).
- E. Bertino, T. Bekaii-Saab, +4 authors M. Villalona-Calero
- Medicine
- Lung cancer
- 2013
INTRODUCTION
This phase II single-arm trial of docetaxel and capecitabine in previously untreated non-small cell lung cancer (NSCLC) patients was designed to evaluate response rate of this regimen… Expand
Pulmonary sarcomatoid carcinoma: University of Cincinnati experience
- N. Karim, J. Schuster, +5 authors J. Morris
- Medicine
- Oncotarget
- 18 December 2017
Objectives To review the outcomes of treatment in patients with pulmonary sarcomatoid carcinoma (PSC) treated at the University of Cincinnati Medical Center (UCMC). Results There was no significant… Expand
Prolonged Survival in a Patient with Metastatic Vasoactive Intestinal Peptide Producing Pancreatic Neuroendocrine Tumors
- N. Karim, A. Zarzour, +4 authors H. Taylor
- Medicine
- 13 October 2012
VIPomas are rare neuroendocrine tumors that secrete vasoactive intestinal peptide. They are detected in 1 in ten million people per year. The majority of these tumors arises within the pancreas, but… Expand
A dose escalation, single arm, phase Ib/II combination study of BEZ235 with everolimus to determine the safety, pharmacodynamics, and pharmacokinetics in subjects with advanced solid malignancies…
- M. Salkeni, M. Beg, +13 authors O. Rixe
- Medicine
- 20 May 2012
TPS3116 Background: Downregulation of a number of signaling pathways, including the mammalian target of rapamycin (mTOR) pathway, has been demonstrated to be efficacious in a large range of solid… Expand
Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis.
- T. Htwe, N. Karim, J. Wong, S. Jahanfar, M. A. Mansur
- Medicine
- Singapore medical journal
- 1 November 2010
INTRODUCTION
Galectin-3 is a member of the beta-galactoside-binding protein family that plays an important role in cell-to-cell adhesion and in cell-to-matrix interaction. Cellular expression of… Expand